Committee
Siegfried Kasper (Austria), Chairman
Dr Siegfried Kasper is Professor of Psychiatry and Head of the Department of Psychiatry and Psychotherapy at the Medical University of Vienna, Austria. He concentrates on the biological bases of mental disorders and their possible treatment approaches. Furthermore, he has conducted studies in psychopathological as well as clinical areas. Dr Kasper is a frequent national and international speaker and continues to be actively involved in research programmes studying depression, anxiety, psychosis, and dementia.
Dr Kasper serves or served on the executive committees and advisory boards of several national and international societies, such as the European College of Neuropsychopharmacology (ECNP) and the Collegium Internationale Neuro-Psychopharmacologicum (CINP). He is president of the Austrian Society of Drug Safety in Psychiatry (ÖAMSP) and past-president of the Austrian Society of Neuropsychopharmacology and Biological Psychiatry (ÖGPB).
Dr Kasper also serves on the editorial boards of numerous learned journals, including International Journal of Neuropsychopharmacology, Journal of Clinical Psychiatry, European Neuropsychopharmacology and European Archives of Psychiatry and Neuroscience. He is co-editor-in-chief of the International Journal of Psychiatry in Clinical Practice.
Stuart A. Montgomery (United Kingdom), Co-Chairman
Stuart Montgomery was Professor of Psychiatry at Imperial College, University of London until his retirement in 1996 when the title of Emeritus Professor of Psychiatry was conferred. He was President of the European College of Neuropsychopharmacology (ECNP) from 1992 to 1995 and President of the British Association of Psychopharmacology from 1990 to 1992.
He has been a member of the Committee on Safety of Medicines. He is Editor of International Clinical Psychopharmacology and was co-Editor of European Neuropsychopharmacology for twenty years. Early in his career he developed the widely used MADRS and he is well known for his research into the treatment of schizophrenia, bipolar disorder, depression and the anxiety disorders.
Scientific Advisers
- Christer Allgulander (Sweden)
- A. Carlo Altamura (Italy)
- Celso Arango (Spain)
- David Baldwin (United Kingdom)
- Michael Bauer (Germany)
- Patrice Boyer (Canada)
- Graham Burrows (Australia)
- Giovanni B. Cassano (Italy)
- Koen Demyttenaere (Belgium)
- J.A. den Boer (The Netherlands)
- T. Dinan (Ireland)
- Elias Eriksson (Sweden)
- Naomi Fineberg (United Kingdom)
- Teruhiko Higuchi (Japan)
- Sidney H. Kennedy (Canada)
- Lars von Knorring (Sweden)
- Jean-Pierre Lépine (France)
- Mario Maj (Italy)
- Aleksander A. Mathé (Sweden)
- Julien Mendlewicz (Belgium)
- Hans-Jürgen Möller (Germany)
- Stefano Pallanti (Italy)
- George Papadimitriou (Greece)
- George Papakostas (USA)
- Zoltan Rihmer (Hungary)
- Alan F. Schatzberg (USA)
- Dan J. Stein (South Africa)
- Trisha Suppes (USA)
- Eduard Vieta (Spain)
- D. Winkler (Austria)
- Shigeto Yamawaki (Japan)
- Joseph Zohar (Israel)
